Strides Pharma Science Limited — Updates, 05-02-2026: Press Release (Revised)
05-02-2026 | 08:49 am
05-02-2026 | 08:49 am
Strides Pharma's US subsidiary received a USFDA inspection closure for its Chestnut Ridge facility, including drug-device combinations. This strengthens its manufacturing capabilities, enhancing US market access and boosting growth prospects.
No comments yet. Be the first to comment!
